Peptide Synthesis

Peptide Synthesis

Global Peptide Synthesis Market to Reach US$541.2 Million by 2030

The global market for Peptide Synthesis estimated at US$402.7 Million in the year 2023, is expected to reach US$541.2 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. Growth in the Synthesizer segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$107.3 Million While China is Forecast to Grow at 7.7% CAGR

The Peptide Synthesis market in the U.S. is estimated at US$107.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$122.4 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Peptide Synthesis Market – Key Trends & Drivers Summarized

How Are Technological Innovations Shaping the Peptide Synthesis Market?

Peptide synthesis has witnessed remarkable advancements due to technological innovations, significantly transforming the efficiency, speed, and scalability of synthesizing peptides for research and therapeutic applications. Traditionally, peptide synthesis was labor-intensive, but recent developments in automated peptide synthesizers and solid-phase peptide synthesis (SPPS) have made the process faster, more reliable, and scalable. These technologies allow the assembly of complex peptide chains with high precision, increasing the yield of synthetic peptides used in drug discovery, diagnostics, and therapeutic development. Innovations such as microwave-assisted peptide synthesis are further improving reaction times and purity levels, allowing for large-scale production of peptides. Additionally, continuous-flow peptide synthesis and new coupling agents are being integrated into workflows to enhance the overall efficiency and reduce production costs. The demand for long and complex peptides, as well as modifications like cyclization and conjugation to other molecules, is growing, driving the need for advanced technologies that can meet the intricate requirements of modern peptide research.

Why Is There a Growing Demand for Peptide Synthesis in Biotechnology and Pharmaceutical Industries?

The biotechnology and pharmaceutical sectors are experiencing a growing demand for peptide synthesis due to the increasing focus on peptide-based drug discovery and development. Peptides, which are short chains of amino acids, play a crucial role as signaling molecules in biological processes, making them valuable in therapeutic applications for conditions such as cancer, metabolic disorders, and infectious diseases. The ability to synthesize custom peptides with specific sequences has opened the door for researchers to explore new drug targets and pathways. As the interest in biologics and targeted therapies grows, synthetic peptides are being used to develop novel therapeutic agents, such as peptide vaccines, enzyme inhibitors, and peptide-based drug delivery systems. Additionally, peptides are widely used as research tools in proteomics and molecular biology, further boosting the demand for high-quality, custom-synthesized peptides. The pharmaceutical industry’s push toward more personalized medicine and biologically relevant therapeutics is driving the need for advanced peptide synthesis technologies capable of producing peptides with high purity and complex structures.

How Are Industry and Research Trends Shaping the Peptide Synthesis Market?

The peptide synthesis market is being shaped by several industry and research trends, particularly the growing focus on developing peptides for therapeutic and diagnostic applications. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is driving demand for peptides as therapeutic agents due to their specificity, low toxicity, and potential for targeting disease pathways with high precision. Furthermore, peptide-based vaccines, especially those being developed for infectious diseases such as COVID-19, are gaining traction as they offer advantages in terms of safety and ease of production. In addition to therapeutic applications, synthetic peptides are being used in the development of biomaterials and diagnostics, expanding their role in various sectors. The rise of peptide libraries, where vast collections of peptides are synthesized and screened for biological activity, is also fueling research in drug discovery. As personalized medicine continues to grow, the role of custom peptide synthesis in developing targeted therapies is becoming increasingly significant, driving investment in peptide synthesis technologies and services.

What Factors Are Driving Growth in the Peptide Synthesis Market?

The growth in the peptide synthesis market is driven by several factors, including advancements in automated synthesis technologies, increasing demand for peptide-based therapeutics, and the rising prevalence of chronic diseases. One key driver is the growing interest in peptides as drug candidates due to their specificity, biocompatibility, and potential for targeted treatments. Additionally, the rapid development of peptide-based vaccines, enzyme inhibitors, and diagnostic tools is fueling demand for custom peptide synthesis. Technological advancements in synthesis methodologies, such as solid-phase peptide synthesis (SPPS), continuous-flow synthesis, and microwave-assisted synthesis, are improving the scalability and efficiency of peptide production, further driving market growth. The biotechnology and pharmaceutical sectors’ focus on biologics and personalized medicine is also contributing to the expansion of the peptide synthesis market. Moreover, the increasing use of synthetic peptides in academic research, drug discovery, and clinical trials is pushing the demand for high-quality peptides with complex modifications. These factors, combined with the growing focus on cost-effective, scalable production methods, are expected to sustain strong growth in the peptide synthesis market.

Select Competitors (Total 22 Featured) -

• Aapptec LLC
• Advanced ChemTech
• AnaSpec, Inc.
• Bachem AG
• Biotage AB
• Cem Corporation
• GenScript Biotech Corporation
• Gyros Protein Technologies AB
• Merck KgaA
• New England Peptide, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.